BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8859304)

  • 1. Retrospective review of the use of azathioprine in severe atopic dermatitis.
    Lear JT; English JS; Jones P; Smith AG
    J Am Acad Dermatol; 1996 Oct; 35(4):642-3. PubMed ID: 8859304
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
    Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
    J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.
    Garritsen FM; van der Schaft J; de Graaf M; Hijnen DJ; Bruijnzeel-Koomen CAF; van den Broek MPH; De Bruin-Weller MS
    Acta Derm Venereol; 2018 Mar; 98(3):373-375. PubMed ID: 29136268
    [No Abstract]   [Full Text] [Related]  

  • 5. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
    Hughes R; Collins P; Rogers S
    Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.
    Murphy LA; Atherton D
    Br J Dermatol; 2002 Aug; 147(2):308-15. PubMed ID: 12174104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of canine atopic dermatitis with azathioprine: a pilot study.
    Favrot C; Reichmuth P; Olivry T
    Vet Rec; 2007 Apr; 160(15):520-1. PubMed ID: 17435099
    [No Abstract]   [Full Text] [Related]  

  • 8. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
    Martel RM; Melwani P; Islas D; Peñate Y; Borrego L
    Actas Dermosifiliogr; 2010 Jun; 101(5):415-20. PubMed ID: 20525484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients.
    Noguera-Morel L; Knöpfel N; Torrelo A; Hernández-Martín A
    Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):227-231. PubMed ID: 30376955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
    Fuggle NR; Bragoli W; Mahto A; Glover M; Martinez AE; Kinsler VA
    J Am Acad Dermatol; 2015 Jan; 72(1):108-14. PubMed ID: 25440430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine.
    Kuanprasert N; Herbert O; Barnetson RS
    Australas J Dermatol; 2002 May; 43(2):125-7. PubMed ID: 11982569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine.
    Garritsen FM; van der Schaft J; Bruijnzeel-Koomen CAF; van Schaik RH; de Graaf M; van den Broek MPH; de Bruin-Weller MS
    J Dermatolog Treat; 2018 Jun; 29(4):375-382. PubMed ID: 28914560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of atopic eczema with calcineurin inhibitors].
    Luger TA; Bieber T; Meurer M; Mrowietz U; Schwarz T; Simon J; Werfel T; Zuberbier T
    J Dtsch Dermatol Ges; 2005 May; 3(5):385-91. PubMed ID: 16372807
    [No Abstract]   [Full Text] [Related]  

  • 16. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.
    Berth-Jones J; Takwale A; Tan E; Barclay G; Agarwal S; Ahmed I; Hotchkiss K; Graham-Brown RA
    Br J Dermatol; 2002 Aug; 147(2):324-30. PubMed ID: 12174106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.
    Thomsen SF; Karlsmark T; Clemmensen KK; Graversgaard C; Ibler KS; Jemec GB; Agner T
    Br J Dermatol; 2015 Apr; 172(4):1122-4. PubMed ID: 25350702
    [No Abstract]   [Full Text] [Related]  

  • 18. [Azatropin in severe atopic dermatitis: 24 cases].
    Malthieu F; Guillet G; Larregue M
    Ann Dermatol Venereol; 2005 Feb; 132(2):168-70. PubMed ID: 15798572
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of azathioprine in severe adult atopic eczema.
    Buckley DA; Baldwin P; Rogers S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):137-40. PubMed ID: 9784039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing clinical use of azathioprine with newer pharmacogenetic data.
    Wolverton SE
    Arch Dermatol; 2009 Jun; 145(6):707-10. PubMed ID: 19528429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.